Syros Pharmaceuticals, Inc.
USD0.00
+0.00 (+0.00%)
CEO
James E. Bradner
IPO Date
2016-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.04
Market Cap
$0.00B
Volume
0.00M
| -0.5 |
| 31 Dec 2021 | FY | 100.0% | -368.5% | -101.6% | -47.3% | 0.76 | 4.33 | -2.4 |
| 31 Dec 2020 | FY | 100.0% | -556.8% | -92.8% | -39.4% | 0.73 | 6.24 | -5.9 |
| 31 Dec 2019 | FY | 100.0% | -3806.2% | -95.3% | -50.3% | 0.33 | 4.87 | -3.7 |
| 31 Dec 2018 | FY | 100.0% | -3038.0% | -79.2% | -58.3% | 0.00 | 5.21 | -2.9 |
| 31 Dec 2017 | FY | -38.7% | -4905.5% | -82.7% | -68.8% | 0.00 | 5.89 | -4.6 |
| 31 Dec 2016 | FY | 100.0% | -15060.9% | -59.2% | -52.3% | 0.00 | 8.94 | -3.2 |
| 31 Dec 2015 | FY | -89.9% | -9406.3% | -87.6% | -68.3% | 0.01 | 4.58 | -1.5 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -22.3% | -21.8% | 0.00 | 48.36 | -3.3 |
| -2.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -24.6% | -2.8% | 4.10 | 3.01 | -13.2 |
| 31 Dec 2023 | Q4 | 27.7% | -16679.8% | -386.4% | -38.3% | 3.73 | 3.95 | -0.9 |
| 30 Sept 2023 | Q3 | 83.6% | -1067.1% | -110.6% | -27.2% | 1.78 | 4.31 | -0.7 |
| 30 Jun 2023 | Q2 | 77.0% | -1279.8% | -49.5% | -20.0% | 0.86 | 5.38 | -0.6 |
| 31 Mar 2023 | Q1 | 76.2% | -505.2% | -14.0% | -7.3% | 0.61 | 7.37 | -1.2 |
| 31 Dec 2022 | Q4 | 114.1% | -504.4% | 21.6% | 11.3% | 0.50 | 6.87 | 0.9 |
| 30 Sept 2022 | Q3 | 81.4% | -541.0% | -16.3% | -7.4% | 0.50 | 6.57 | -0.7 |
| 30 Jun 2022 | Q2 | 88.4% | -560.8% | -113.5% | -27.9% | 2.15 | 2.36 | -0.4 |